Clinical implications of enteroadherent escherichia coli

Current Gastroenterology Reports

Volumn 14, Issue 5, 2012, Pages 386-394

  Arenas Hernández, Margarita M P ^a   Martínez Laguna, Ygnacio ^a   Torres, Alfredo G ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Adherence; Diarrhea; Enteroaggregative E. coli; Enteropathogenic E. coli; Enterotoxigenic E. coli; Pathogenic Escherichia coli; Virulence

Indexed keywords

ACE 527; AMPICILLIN; AZITHROMYCIN; CEFTAZIDIME; CEFTRIAXONE; CHOLERA VACCINE; CIPROFLOXACIN; CYCLIC GMP; ESCHERICHIA COLI ENTEROTOXIN; ESCHERICHIA COLI VACCINE; GUANYLATE CYCLASE; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAXIMIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBODY RESPONSE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; DIAGNOSTIC VALUE; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ENTEROADHERENT ESCHERICHIA COLI; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; HUMAN; IMMUNOGENICITY; INTESTINE BRUSH BORDER; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; ORAL REHYDRATION THERAPY; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEROTYPING; TRAVELLER DIARRHEA;

BACTERIAL ADHESION; DIARRHEA; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; VIRULENCE;

EID: 84870519965     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0277-1     Document Type: Review

References (71)

1. Torres AG, Zhou X, Kaper JB. Adherence of diarrheagenic Escherichia coli strains to epithelial cells. Infect Immun. 2005; 73:18-29.
2. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123-40.
3. WHO. Future Directions for Research on Enterotoxigenic Escherichia coli Vaccines for Developing Countries. Wkly Epidemiol Rec. 2006;81:97-104.
4. Wang M, Szucs TD, Steffen R. Economic aspects of travelers' diarrhea. J Travel Med. 2008;15:110-8.
5. Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun. 2007;75:3961-8.
6. Fleckenstein JM, Hardwidge PR, Munson GP, Rasko DA, Sommerfelt H, Steinsland H. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010;12:89-98.
7. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev. 2005;18:465-83.
8. Svennerholm AM, Tobias J. Vaccines against enterotoxigenic Escherichia coli. Expert Rev Vaccines. 2008;7:795-804.
9. Gaastra W, Svennerholm AM. Colonization factors of human enterotoxigenic Escherichia coli (ETEC). Trends Microbiol. 1996;4:444-52.
10. Turner SM, Scott-Tucker A, Cooper LM, Henderson IR.Weapons of mass destruction: Virulence factors of the global killer enterotoxigenic Escherichia coli. FEMS Microbiol Lett. 2006;263:10-20.
11. Dorsey FC, Fischer JF, Fleckenstein JM. Directed delivery of heatlabile enterotoxin by enterotoxigenic Escherichia coli. Cell Microbiol. 2006;8:1516-27.
12. Johnson AM, Kaushik RS, Francis DH, Fleckenstein JM, Hardwidge PR. Heat-labile enterotoxin promotes Escherichia coli adherence to intestinal epithelial cells. J Bacteriol. 2009;191:178-86.
13. Lasaro MA, Mathias-Santos C, Rodrigues JF, Ferreira LC. Functional and immunological characterization of a natural polymorphic variant of a heat-labile toxin (LT-I) produced by enterotoxigenic Escherichia coli (ETEC). FEMS Immunol Med Microbiol. 2009;55:93-9.
14. Yoder JS, Cesario S, Plotkin V, Ma X, Kelly-Shannon K, Dworkin MS. Outbreak of enterotoxigenic Escherichia coli infection with an unusually long duration of illness. Clin Infect Dis. 2006;42:1513-7.
15. Hill DR. Occurrence and self-treatment of diarrhea in a large cohort of Americans traveling to developing countries. AmJTrop Med Hyg. 2000;62:585-9.
16. Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N. Vaccination against enterotoxigenic Escherichia coli, a cause of travellers' diarrhea. J Travel Med. 2005;12:102-7.
17. Sack DA, Shimko J, Torres O, Bourgeois AL, Francia DS, Gustafsson B, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travellers to Guatemala and Mexico. Vaccine. 2007;25: 4392-400.
18. DuPont HL, Haynes GA, Pickering LK, TjoaW, Sullivan P, Olarte J. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol. 1977;105:37-41.
19. Svennerholm AM. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development. Indian J Med Res. 2011;133: 188-94.
20. Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, et al. Combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults. Clin Vaccine Immunol. 2011;18:2118-27. This report describes the safety and immunogenicity results from the first-in-human dose-escalation trial of ACE527, a three live attenuated ETEC vaccine strains that collectively express several CSs and LTB.
21. Crossman LC, Chaudhuri RR, Beatson SA, Wells TJ, Desvaux M, Cunningham AF, et al. A commensal gone bad: Complete genome sequence of the prototypical enterotoxigenic Escherichia coli strain H10407. J Bacteriol. 2010;192:822-31. This paper describes for the first time the complete genomic sequence of E. coli H10407, a prototypical strain of enterotoxigenic E. coli.
22. Harris JA, Roy K, Woo-Rasberry V, Hamilton DJ, Kansal R, Qadri F, et al. Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates. PLoS Negl Trop Dis. 2011;5:e1428.
23. Wagner A, Wiedermann U. Travellers' diarrhoea-pros and cons of different prophylactic measures. Wien Klin Wochenschr. 2009;121:13-8.
24. Frech SA, Dupont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: A phase II, randomised, double-blind, placebo-controlled field trial. Lancet. 2008;371:2019-25.
25. Flores J, Okhuysen PC. Enterotoxigenic Escherichia coli. In: Torres AG, editor. Pathogenic Escherichia coli in Latin America. Bentham Sciencie Publishers Ltd.; 2010. pp. 84-94.
26. Koo HL, DuPont HL. Rifaximin: A unique gastrointestinalselective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010;26:17-25. This review describes the most recent advances in rifaximin treatment and prevention of travelers' diarrhea.
27. Koo HL, DuPont HL, Huang DB. The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea. Ther Clin Risk Manag. 2009;5:841-8.
28. Lapointe TK, O'Connor PM, Buret AG. The role of epithelial malfunction in the pathogenesis of enteropathogenic E. coli-induced diarrea. Lab Invest. 2009;89:964-70.
29. Wong AR, Pearson JS, Bright MD, Munera D, Robinson KS, Lee SF, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: Even more subversive elements. Mol Microbiol. 2011;80: 1420-38.
30. Bardiau M, Szalo M, Mainil JG. Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res. 2010;41:57.
31. Humphries RM, Armstrong GD. Sticky situation: Localized adherence of enteropathogenic Escherichia coli to the small intestine epithelium. Future Microbiol. 2010;5:1645-61.
32. Gomes TAT, Gonzalez-Pedrajo B. Enteropathogenic Escherichia coli (EPEC). In: Torres AG, editor. Pathogenic Escherichia coli in Latin America.: Betham Science Publishers Ltd; 2010. pp. 25-47.
33. Hernandes RT, Elias WP, Vieira MAM, Gomes TAT. An overview of atypical enteropathogenic Escherichia coli. FEMS Microbiol Lett. 2009;297:137-49.
34. Scaletsky ICA, Souza TB, Aranda KRS, Okeke IN. Genetic elements associated with antimicrobial resistance in enteropathogenic Escherichia coli (EPEC) from Brazil. BMC Microbiol. 2010;10:25.
35. Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis. 2011;24:478-83. This review discussed the current knowledge about atypical EPEC as a human pathogen.
36. Bugarel M, Martin A, Fach P, Beutin L. Virulence gene profiling of enterohemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli strains: A basis for molecular risk assessment of typical and atypical EPEC strains. BMC Microbiol. 2011;11:142.
37. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol. 2010;8:26-38.
38. Calderon Toledo C, Arvidsson I, Karpman D. Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model. Infect Immun. 2011;79:2224-33. Using a murine model of infection, this study shows that enteropathogenic E. coli infections may protect against enterohemorrhagic E. coli infections.
39. Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology. 2009;136:1874-86.
40. Hodges K, Gill R. Infectious diarrea. Cellular and molecular mechanisms. Gut Microb. 2010;1:4-21.
41. Abba K, Sinfield R, Hart CA, Garner P. Pathogens associated with persistent diarrhea in children in low and middle income countries: Systematic review. BMC Infect Dis. 2009;9:88.
42. García PG, Silva VL, Dinis CG. Ocurrence and antimicrobial Drug Susceptibility Patterns of commensal and diarrheagenic Escherichia coli in fecal microbiota from children with and without acute diarrhea. J Microbiol. 2011;49:46-52.
43. Ochoa TJ, Barletta F, Contreras C, Mercado E. New insights into the epidemiology of enteropathogenic Escherichia coli infection. Trans R Soc Trop Med Hyg. 2008;102:852-6.
44. Fagundes-Neto U, Scaletsky IC. The gut at war: The consequences of enteropathogenic Escherichia coli infection as a factor of diarrhea and malnutrition. Sao Paulo Med J. 2000;118:21-9.
45. Liu ZH, Shen TY, Zhang P, Ma YL, Moyer MP, Qin HL. Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460.World J Gastroenterol. 2010;16:5759-65.
46. Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis. 2008;2008:290769.
47. Hardegen C, Messler S, Henrich B, Pfeffer K, Würthner J, MacKenzie CR. A set of novel multiplex Taqman real-time PCRs for the detection of diarrhoeagenic Escherichia coli and its use in determining the prevalence of EPEC and EAEC in a university hospital. Ann Clin Microbiol Antimicrob. 2010;9:5.
48. Mainil JG, Bardiau M, Ooka T, Ogura Y, Murase K, Etoh Y, et al. Typing of O26 enterohaemorrhagic and enteropathogenic Escherichia coli isolated from humans and cattle with IS621 multiplex PCR-based fingerprinting. J Appl Microbiol. 2011;111: 773-86.
49. Bouzari S, Aslani MM, Oloomi M, Jafari A, Dashti A. Comparison of multiplex PCR with serogrouping and PCR-RFLP of fliC gene for the detection of enteropathogenic Escherichia coli (EPEC). Braz J Infect Dis. 2011;15:365-9.
50. Botkin DJ, Galli L, Sankarapani V, Soler M, Rivas M, Torres AG. Development of a Multiplex PCR Assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains. Front Microbiol. 2012;2:1. This new mPCR methodology permitted the differentiation of enteropathogenic E. coli, Shiga toxin-producing E. coli, and enterohemorrhagic E. coli strains from other pathogenic E. coli.
51. Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol. 2009;25:8-11.
52. Harrington SM, Dudley EG, Nataro JP. Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 2006;254:12-8.
53. Weintraub A. Enteroaggregative Escherichia coli: Epidemiology, virulence and detection. J Med Microbiol. 2007;56:4-8.
54. Andrade JA, Freymüller E, Fagundes-Neto U. Adherence of enteroaggregative Escherichia coli to the ileal and colonic mucosa: Anin vitro study utilizing the scanning electron microscopy. Arq Gastroenterol. 2011;48:199-204.
55. Dudley EG, Abe C, Ghigo JM, Latour-Lambert P, Hormazabul JC, Nataro JP. An IncI1 plasmid contributes to the adherence of the atypical enteroaggregative Escherichia coli strain C1096 to cultured cells and abiotic surfaces. Infect Immun. 2006;74:2102-14.
56. Abe CM, Knutton S, Pedroso MZ, Freymüller E, Gomes TA. An enteroaggregative Escherichia coli strain of serotype O111:H12 damages and invades cultured T84 cells and human colonic mucosa. FEMS Microbiol Lett. 2001;203:199-205.
57. Pereira AC, Britto-Filho JD, de Carvalho JJ, das Gracas de Luna M, Rosa AC. Enteroaggregative Escherichia coli (EAEC) strains enter and survive within cultured epithelial cells. Microb Pathog. 2008;45:310-4.
58. Sobieszczanska B, Duda AK, Turniak M, Duda-Madej A, Franiczek R, Kasprzykowska U. Characterization of genes associated with internalization of enteroaggregative Escherichia coli. Microb Pathog. 2011;50:141-7.
59. Konno T, Yatsuyanagi J, Saito S. Virulence gene profiling of enteroaggregative Escherichia coli heat-stable enterotoxin 1-harboring E. coli (EAST1EC) derived from sporadic diarrheal patients. FEMS Immunol Med Microbiol. 2011;[Epub ahead of print].
60. Navarro-Garcia F. Enteroaggregative Escherichia coli plasmidencoded toxin. Future Microbiol. 2010;5:1005-13.
61. Cappello RE, Estrada-Gutierrez G, Irles C, Giono-Cerezo S, Bloch RJ, Nataro JP. Effects of the plasmid-encoded toxin of enteroaggregative Escherichia coli on focal adhesion complexes. FEMS Immunol Med Microbiol. 2011;61:301-14.
62. Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S, Simon J, et al. Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis. 2012;205:431-44. In this paper, an mPCR and comparative genome hybridization analysis of a collection of enteroaggregative E. coli (EAEC) strains was performed, and a subset of EAEC strains that are pathogenic was defined, including the identification of a marker for the most virulent isolates.
63. Edwards LA, Bajaj-Elliott M, Klein NJ, Murch SH, Phillips AD. Bacterial-epithelial contact is a key determinant of host innate immune responses to enteropathogenic and enteroaggregative Escherichia coli. PLoS One. 2011;6:e27030. This paper characterizes which bacterial motifs contribute to the innate epithelial response to enteropathogenic E. coli and enteroaggregative E. coli, using a range of E. coli isogenic mutant strains.
64. Boll EJ, Struve C, Sander A, Demma Z, Krogfelt KA, McCormick BA. Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway. Cell Microbiol. 2012;14:120-32. This paper found that polymorphonuclear neutrophils (PMN) transepithelial migration promoted enhanced attachment of enteroaggregative E. coli (EAEC) to T84 cells and suggested that EAEC-induced PMN infiltration may favor colonization and, thus, pathogenesis of EAEC.
65. Aslani MM, Alikhani MY, Zavari A, Yousefi R, Zamani AR. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern. Int J Infect Dis. 2011;15:e136-9.
66. Mortensen NP, Fowlkes JD, Maggart M, Doktycz MJ, Nataro JP, Drusano G, et al. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin. Int J Antimicrob Agents. 2011;38:27-34.
67. Ouyang-Latimer J, Jafri S, VanTassel A, Jiang ZD, Gurleen K, Rodriguez S, et al. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. Antimicrob Agents Chemother. 2011;55:874-8.
68. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: A putative new E. coli pathotype associated with Crohn's disease. Int J Med Microbiol. 2002;292:185-93.
69. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-21.
70. Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008;298: 397-409.
71. Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, et al. Genome sequence of adherentinvasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics. 2010;11:667.